FaceBank Group, Inc. (d/b/a fuboTV) (OTCQB: FUBO) today released its first letter to shareholders, which includes select audited financial results from fuboTV on a stand-alone basis for the year ended December 31, 2019, and certain […]
SAN DIEGO, May 5, 2020 —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]
NEW YORK and TORONTO, May 05, May 05, 2020 (GLOBE NEWSWIRE via COMTEX) — NEW YORK and TORONTO, May 05, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leader in […]
FaceBank Group, Inc. (d/b/a fuboTV) announced today that the company’s ticker symbol on the OTCQB has changed to “FUBO” from “FBNK” effective tomorrow at market open. The number of shares outstanding of the registrant’s common […]
54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]
FaceBank Group, Inc. (d/b/a fuboTV) (OTCQB: FBNK) announced today that its Board of Directors has appointed Edgar Bronfman Jr. to the Board of Directors and has named him Executive Chairman effective immediately. As Executive Chairman […]
The combined companies launching AR first Virtual Conferences NEW YORK and TORONTO, April 30, Apr 30, 2020 — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leader in augmented reality for eCommerce […]
FaceBank Group, Inc. d/b/a fuboTV [OTCQB:FBNK] CEO David Gandler was featured in a discussion led by Michael Pachter, Managing Director of Digital Media Equity Research at Wedbush Securities, to dive deeper into trends around cord-cutting, […]
Contract Revenue is $300,000USD Plus 5 Year Management Program Revenue Fees VANCOUVER and ERIE, PA, April 29, 2020 – Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) (“ImagineAR” or “Company”) is pleased to announce the signing of a […]
Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]
VANCOUVER, Washington, Apr 27, 2020 — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]
VANCOUVER, Washington, Apr 24, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]
NEW YORK and TORONTO, April 23, Apr 23, 2020 — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for eCommerce and AR learning applications, is pleased to update […]
The Company’s Phase 2b/3 trial is for patients with severe and critically ill COVID-19 indications. Interim analysis will be conducted after results for first 50 patients are available. VANCOUVER, Washington, Apr 15, 2020 — CytoDyn […]
VANCOUVER, Washington, Apr 13, 2020 — More than 25 EINDs approved by FDA for leronlimab use in COVID-19 patients Phase 2 trial – As of last week, 12 patients enrolled from 2 sites; 3 more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
